Desang diabetes magazine diabetes news

NEWS

PODIATRIST WINS AWARD

Marie Stirling, a diabetes podiatrist

working in Dr Grays, an acute NHS

hospital clinic within NHS Grampian, has

won this year's Cosyfeet Podiatry Award.

She will use the money to help fund a

trial to compare traditional 'total contact

casting' (TCC) with a new roll-on method

(the TCC-EZ device) used to offload

pressure from diabetic foot ulcers.

TCC is the gold standard for offloading

pressure from ulcers in suitable diabetic

patients, but whether this treatment

is offered may be a bit of a 'postcode

lottery' due to a variety of factors,

including access to training and the timeconsuming application method.

The new

roll-on TCC-EZ device, although more

expensive, is thought to be quicker and

easier to apply, and could prove more

cost-effective for the NHS to administer

to appropriate patients.

The Cosyfeet Podiatry Award assists

podiatrists and podiatry students to

develop their professional knowledge

and skills while benefitting others. The

award is open to those who are planning

voluntary work, a work placement or

research, whether in the UK or abroad.

"We're delighted to be able to help with

such vital research, which will inform best

practice as regards offloading to heal

ulcers in certain diabetic patients", says

Managing Director Andrew Peirce. "The

knowledge gained can be used to advise

NHS policy geared to reducing numbers

of amputations due to non-healing

wounds.

www.cosyfeet.com

Podiatrist Marie Stirling

JDRF has announced a partnership with

Arecor Ltd to support development of a

stable, rapid-acting, ultra-concentrated

insulin. Improved insulins would enable

the miniaturization of next-generation

insulin-delivery devices for people with

Type 1 diabetes. The aim is to advance

the pre-clinical trials of Arecor's ultraconcentrated insulin. The ultimate goal

of the partnership is to accelerate the

development of a stable, rapid-acting,

ultra-concentrated insulin of up to 1,000

U/mL, which will not only offer a vastly

superior mealtime insulin product for

people requiring less than 200 units a

day, but is also a critical step towards

the advancement of the miniaturization of

delivery devices, including next-generation

artificial pancreas systems for people with

Type 1 diabetes.

JDRF PARTNERS

FOR FASTER

INSULIN

Islexa is a new bio-tech start-up which

will be developing laboratory grown

islets cells the aim being to replace

insulin production in people with Type 1

diabetes. Islexa is built on research from

University of Aberdeen, which looked into

re-programming normal pancreatic tissue

into fully functional islets (the clusters

of cells that produce insulin). Islexa's

laboratory grown islets are meant to

bring islet transplants to more diabetes

patients. While this procedure has shown

efficacy, there is a shortage of suitable

donor organs - and the extraction of islets

is also complicated.

Islet transplants are particularly

important for patients with hypo

unawareness (few symptoms of a falling

blood sugar level), approximately 10%

of all T1Ds. Islet transplants are effective

in the long-term, so patients should not

need insulin injections.

The creation of Islexa follows

successful results in pre-clinical studies,

which the new company will explore

further. The next stage is to take the

technology into clinical trials, which are

expected in the next few years. Islexa

is receiving support from Catapult,

which helps cell therapies break into the

market, and the University of Aberdeen.

Other partners include the Scottish Islet

Transplant Programme, the University

of Edinburgh and the Scottish National

Blood Transfusion Service (SNBTS).

www.labiotech.eu

ISLETS FROM SCOTLAND

To read about the Accelerator Hypothesis and

beta cell die-off, see our feature on p. 12.

Index

  1. Desang diabetes magazine diabetes information
  2. Abbott Freestyle Libre, Flash Glucose Monitoring, blood testing without lancets
  3. Desang diabetes magazine diabetes information, Sue Marshall
  4. Desang diabetes magazine diabetes news
  5. Desang diabetes magazine diabetes news
  6. Desang diabetes magazine diabetes news
  7. Accu-Chek Mobile blood glucose system
  8. Desang diabetes magazine diabetes diet
  9. Desang diabetes magazine diabetes diet
  10. diabetes kit, Ascensia Diabetes Care, Contour Next One
  11. diabetes kit, Ascensia Diabetes Care, Contour Next One
  12. The Accelerator Hypothesis, Professor Terry Wilkin, the ADAPT trial, cure for Type 1 diabetes
  13. The Accelerator Hypothesis, Professor Terry Wilkin, the ADAPT trial, cure for Type 1 diabetes
  14. The Accelerator Hypothesis, Professor Terry Wilkin, the ADAPT trial, cure for Type 1 diabetes
  15. Ascensia Contour Diabetes blood test meters
  16. The Accelerator Hypothesis, Professor Terry Wilkin, the ADAPT trial, cure for Type 1 diabetes
  17. The Accelerator Hypothesis, Professor Terry Wilkin, the ADAPT trial, cure for Type 1 diabetes
  18. The Accelerator Hypothesis, Professor Terry Wilkin, the ADAPT trial, cure for Type 1 diabetes
  19. Hid-In insulin pump belts, Leather ICE medical ID
  20. cured food, diabetes food, diabetes food news, desang diabetes magazine food news
  21. cured food, diabetes food, diabetes food news, desang diabetes magazine food news
  22. Making Carbs Count Aubergines
  23. Carb and nutrient value of onions and their value in the diabetic diet
  24. Carb and nutrient value of onions and their value in the diabetic diet
  25. Accu-Chek Insight insulin pump
  26. Living with diabetes, the diabetic diet, carb counting

Related Issues

powered by PageTiger